Dowling & Yahnke LLC Abbott Laboratories Transaction History
Dowling & Yahnke LLC
- $215 Million
- Q3 2022
A detailed history of Dowling & Yahnke LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Dowling & Yahnke LLC holds 79,018 shares of ABT stock, worth $10.6 Million. This represents 3.56% of its overall portfolio holdings.
Number of Shares
79,018
Previous 79,838
1.03%
Holding current value
$10.6 Million
Previous $8.67 Million
11.85%
% of portfolio
3.56%
Previous 0.41%
Shares
20 transactions
Others Institutions Holding ABT
# of Institutions
3,542Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$22.7 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.4 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.95 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.8 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $235B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...